ICP monitoring	control group	Hematoma enlargement	1048	1203	There was no significant between-group difference in the incidence of hematoma enlargement (control group, 38.6% vs. ICP monitoring group, 32.6%; P > 0.05)
ICP monitoring	control group	Secondary brain herniation.	1254	1366	in the ICP monitoring group was significantly lower compared with the control group (10.9% vs. 20.5%, P = 0.04).
ICP monitoring	control group	Secondary brain herniation.	1205	1365	The incidence rate of secondary brain herniation in the ICP monitoring group was significantly lower compared with the control group (10.9% vs. 20.5%, P = 0.04)
ICP monitoring	control group	Mortality	1367	1454	Six-month mortality was 6.5% in the ICP group and 9.1% in the control group (P < 0.05),
ICP monitoring	control group	neurological status	-1	-1	neurological outcome was better in the ICP group compared with the control group (P < 0.05).<NEWLINE> <NEWLINE><NEWLINE> <NEWLINE><NEWLINE> <NEWLINE>Conclusion
